Cargando…

Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention

We aimed to estimate the utility of panel‐based pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI). Utilization of Clinical Pharmacogenetic Implementation Consortium (CPIC) level A/B drugs after PCI was estimated in a national sample of IBM MarketScan beneficiari...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Rouby, Nihal, Alrwisan, Adel, Langaee, Taimour, Lipori, Gloria, Angiolillo, Dominick J, Franchi, Francesco, Riva, Alberto, Elsey, Amanda, Johnson, Julie A., Cavallari, Larisa H., Winterstein, Almut G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214641/ https://www.ncbi.nlm.nih.gov/pubmed/31758664 http://dx.doi.org/10.1111/cts.12729

Ejemplares similares

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
por: Cavallari, Larisa H., et al.
Publicado: (2018)

Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure
por: Sarhan, Neven M., et al.
Publicado: (2019)

Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US
por: Wang, Yehua, et al.
Publicado: (2023)

2235: Equipping health professional students to apply pharmacogenomic data to clinical decision making in real-world scenarios: Comparison of an active engagement Versus didactic teaching approach
por: Arwood, Meghan J., et al.
Publicado: (2018)

Tailoring P2Y(12) Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Capranzano, Piera, et al.
Publicado: (2019)

Pharmacogene regulatory elements: from discovery to applications
por: Smith, Robin P, et al.
Publicado: (2012)

Identification, conservation, and expression of tiered pharmacogenes in zebrafish
por: Demery-Poulos, Catherine, et al.
Publicado: (2022)

Genetic Variation among Pharmacogenes in the Sardinian Population
por: Idda, Maria Laura, et al.
Publicado: (2022)

CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
por: Beitelshees, Amber L., et al.
Publicado: (2022)

Ontogeny-related pharmacogene changes in the pediatric liver transcriptome
por: Meier, Richard, et al.
Publicado: (2018)

Pharmacogene Variation Consortium Gene Introduction: NUDT15
por: Yang, Jun J., et al.
Publicado: (2018)

Sex-Biased Expression of Pharmacogenes across Human Tissues
por: Idda, Maria Laura, et al.
Publicado: (2021)

Comprehensive characterization of pharmacogenes in a Taiwanese Han population
por: Lu, Hsing-Fang, et al.
Publicado: (2022)

Quantification of spatial pharmacogene expression heterogeneity in breast tumors
por: Powell, Nicholas R., et al.
Publicado: (2022)

Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Evaluating the Extent of Reusability of CYP2C19 Genotype Data among Patients Genotyped for Antiplatelet Therapy Selection
por: Beitelshees, Amber L., et al.
Publicado: (2020)

Learning from biomedical linked data to suggest valid pharmacogenes
por: Dalleau, Kevin, et al.
Publicado: (2017)

Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes
por: Caspar, Sylvan M., et al.
Publicado: (2020)

Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform
por: Kim, Byungwook, et al.
Publicado: (2021)

Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
por: Tilleman, Laurentijn, et al.
Publicado: (2022)

Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention
por: Sweeny, Joseph M., et al.
Publicado: (2017)

Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
por: Galli, Mattia, et al.
Publicado: (2023)

Analytical validation of GenoPharm a clinical genotyping open array panel of 46 pharmacogenes inclusive of variants unique to people of African ancestry
por: Kanji, Comfort Ropafadzo, et al.
Publicado: (2023)

Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center
por: Waheed, Nida, et al.
Publicado: (2021)

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations
por: Cho, Sung Won, et al.
Publicado: (2019)

Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines
por: Chhibber, A, et al.
Publicado: (2017)

Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences
por: Lee, Seung‐been, et al.
Publicado: (2019)

Combination of Genome-Wide Polymorphisms and Copy Number Variations of Pharmacogenes in Koreans
por: Han, Nayoung, et al.
Publicado: (2021)

Genetic landscape of 125 pharmacogenes in Chinese from the Chinese Millionome Database
por: Qi, Guangzhao, et al.
Publicado: (2021)

Genetic diversity of ‘Very Important Pharmacogenes’ in two South-Asian populations
por: Bharti, Neeraj, et al.
Publicado: (2021)

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes
por: Fracowiak, Jochen, et al.
Publicado: (2022)

Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
por: Chen, Yuanhuang, et al.
Publicado: (2021)

P2Y(12) Inhibitor Monotherapy after Percutaneous Coronary Intervention
por: Zhou, Xuan, et al.
Publicado: (2022)

Antidepressant Use During Pregnancy and the Potential Risks of Motor Outcomes and Intellectual Disabilities in Offspring: A Systematic Review
por: Al-Fadel, Nouf, et al.
Publicado: (2021)

Characterizing OPRM1 DNA methylation in prescription opioid users with chronic musculoskeletal pain
por: Sheikh, Sophia, et al.
Publicado: (2022)

Exploring VEGF-Linked Pathways: Investigating Multiple miRNAs for Their Therapeutic Potential in Angiogenesis Targets and as Biomarkers in Recurrent Glioblastoma Multiforme
por: Hadizadeh, Morteza, et al.
Publicado: (2022)

Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting
por: Buccheri, Sergio, et al.
Publicado: (2019)

Implications of Polymorphisms in the BCKDK and GATA‐4 Gene Regions on Stable Warfarin Dose in African Americans
por: Bargal, Salma A., et al.
Publicado: (2020)

Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned
por: Weitzel, Kristin W., et al.
Publicado: (2018)

Covid-19 Vaccine Surveillance in Saudi Arabia: Opportunities for Real-time Assessment
por: Albogami, Yasser, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h4r1c30v4fmopo21tg2oj5u5cp